Skip to main content
OpenTrials

Clinical trial condition

Leukemia

Explore clinical trials studying Leukemia. Study availability and eligibility vary by location and protocol.

1,702 public trials 177 recruiting studies
Refine in advanced search Browse all conditions

Leukemia trial results

Completed

A Study of Dasatinib in Patients With Chronic Myelogenous Leukemia Who Are Resistant or Intolerant of Imatinib Mesylate

NCT00298987

Conditions
Blast Crisis, Bone Marrow Diseases, Carcinogenesis, +22 more
Locations
  • Local Institution Corona, California, United States
  • Local Institution Aurora, Colorado, United States
  • Local Institution Colorado Springs, Colorado, United States
  • Local Institution Waterford, Connecticut, United States
View all 35 locations
View Trial Details
Completed

Rasburicase Versus Allopurinol in Tumor Patients at Risk for Hyperuricemia and Tumor Lysis Syndrome

NCT00230178

Conditions
Bone Marrow Diseases, Cancer, Hematologic Diseases, +14 more
Locations
  • Alta Bates Comprehensive Cancer Center Berkeley, California, United States
  • UCLA Medical Center Los Angeles, California, United States
  • Rocky Mountain Cancer Center Denver, Colorado, United States
  • University of Florida Health Science Center at Jacksonville Jacksonville, Florida, United States
View all 15 locations
View Trial Details
Completed

Study of XIAP Antisense Given With Chemotherapy for Refractory/Relapsed AML

NCT00363974

Conditions
Disease Attributes, Hematologic Diseases, Hemic and Lymphatic Diseases, +8 more
Locations
  • Norris Cancer Center - University of Southern California Los Angeles, California, United States
  • UCLA Medical Center Los Angeles, California, United States
  • Northwestern Memorial Hospital Chicago, Illinois, United States
  • Johns Hopkins - Sidney Kimmel Comprehensive Cancer Center Baltimore, Maryland, United States
View Trial Details
Completed

Busulfan in Treating Children and Adolescents With Refractory CNS Cancer

NCT00006246

Conditions
Astrocytoma, Brain Diseases, Brain Neoplasms, +57 more
Locations
  • UCSF Cancer Center and Cancer Research Institute San Francisco, California, United States
  • Children's National Medical Center Washington D.C., District of Columbia, United States
  • Dana-Farber Cancer Institute Boston, Massachusetts, United States
  • Duke Comprehensive Cancer Center Durham, North Carolina, United States
View Trial Details
Completed

Voriconazole for Secondary Prophylaxis of Invasive Fungal Infections in Patients With Allogeneic Stem Cell Transplants

NCT00143312

Conditions
Bacterial Infections and Mycoses, Hematologic Diseases, Hemic and Lymphatic Diseases, +7 more
Locations
  • Pfizer Investigational Site Leuven, Belgium
  • Pfizer Investigational Site Marseille, Cedex 09, France
  • Pfizer Investigational Site Créteil, France
  • Pfizer Investigational Site Nantes, France
View all 17 locations
View Trial Details

Related conditions